Metabolic Oncology: From Theory To Clinical Application | Dr. Tomás Duraj | The Metabolic Link Ep. 84
About this episode
Dr. Tomás Duraj discusses the potential of ketogenic metabolic therapy in treating glioblastoma and its clinical applications.
Glioblastoma has a long-term survival rate under 1% at ten years. After decades of research focusing primarily on mutation-targeted therapies, median survival has improved by only a few months. Dr. Tomás Duraj believes there's a better path forward. Dr. Duraj is a physician-scientist at Boston College working on the metabolic vulnerabilities of cancer. In this Metabolic Health Summit presentation, he outlines a clinical framework for studying ketogenic metabolic therapy — one built on biomark...
People in this episode
Hosts: Dr. Dominic D'Agostino, Dr. Angela Poff, Victoria Field
Guest: Dr. Tomás Duraj
Topics covered
- metabolic oncology
- glioblastoma
- ketogenic therapy
- cancer research
- clinical application
Keywords
- glioblastoma
- metabolic vulnerabilities
- ketogenic therapy
- cancer
- clinical framework
Mentioned in this episode
Organizations: Boston College
More episodes of The Metabolic Link
- Understanding Female Metabolism: PCOS, Postpartum, and Menopause | Madison Kackley, PhD | The Metabolic Link
- Vagal Nerve Stimulation, TBI, and Brain Health: Rethinking Neurological Care | Dr. Michael Hoffman, MD | The Metabolic Link Ep. 92
- What's in Your Tap Water? Contaminants, Filtration, and How to Test It | Johnny Pujol | The Metabolic Link Ep. 91
- Rethinking Cognitive Decline: Stimulus, Exercise, and the Aging Brain | Dr. Tommy Wood, MD, PhD | The Metabolic Link Ep. 90
- Journal Club: Five Papers Pushing the Boundaries of Metabolic Therapy | The Metabolic Link Ep. 89
- Mitochondria, Muscle, & Aging: What Longevity Drugs Miss | Dr. Mark Tarnopolsky | The Metabolic Link Ep. 88
Explore listener stats, chart rankings, contacts and more on the The Metabolic Link podcast page.